[Federal Register Volume 63, Number 228 (Friday, November 27, 1998)]
[Notices]
[Page 65602]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-31635]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of
the National Cancer Advisory Board.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(6) and 552b(c)(9)(B), Title 5
U.S.C. and section 10(d) of the Federal Advisory Committee Act, as
amended, for discussions pertaining to NCI personnel and programmatic
issues. These discussions could reveal information of a personal nature
where disclosure would constitute a clearly unwarranted invasion of
personal privacy and would be likely to significantly frustrate the
subsequent implementation of personnel and programmatic recommendations
made during these discussions.
Name of Committe: National Cancer Advisory Board.
Date: December 8-9, 1998.
Open: December 8, 1998, 8:30 am to 4:00 pm and December 9, 1998,
8:30 am to 1:00 pm.
Agenda: Report of the Director, National Cancer Institute;
Overview of Board of Scientific Advisors activities; Intramural and
Extramural Program Overviews and Updates; Presentations by various
NCI working groups on current and proposed program activities,
projects and initiatives; other NCAB business.
Place: National Cancer Institute, 9000 Rockville Pike, Building
31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 20892.
Closed: December 8, 1998, 4:00 pm to 5:30 pm.
Agenda: To review and evaluate discussion of Intramural site
visits, proprietary, programmatic and personnel issues. Review and
discussion of Extramural proprietary, programmatic and personnel
issues.
Place: National Cancer Institute, 9000 Rockville Pike, Building
31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 20892.
Contact Person: Dr. Marvin R. Kalt, Executive Secretary,
Division of Extramural Activities, National Cancer Institute,
National Institutes of Health, Executive Plaza North, Suite 600,
6130 Executive Boulevard, Rockville, MD 20892, (301) 496-5147.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: November 19, 1998.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 98-31635 Filed 11-25-98; 8:45 am]
BILLING CODE 4140-01-M
